Hana Must SPAC 2 Total Assets
Hana Must SPAC 2 total assets. Based on the latest financial reports, Hana Must SPAC 2 (208370) holds total assets worth ₩70.83 Billion KRW (≈ $48.00 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of Hana Must SPAC 2 for the company's overall valuation and market capitalisation.
Total Assets of Hana Must SPAC 2 (2015–2024)
Total assets of Hana Must SPAC 2 from 2015 to 2024. This chart illustrates how Hana Must SPAC 2's total assets have evolved over time, based on quarterly financial data. See Hana Must SPAC 2 (208370) stock price for real-time trading data and today's change.
Hana Must SPAC 2 - Asset Composition Analysis
Hana Must SPAC 2 Total Assets Breakdown (December 2024)
Hana Must SPAC 2 total assets breakdown as of December 2024. Hana Must SPAC 2's total assets of ₩70.83 Billion consist of 62.6% current assets and 37.4% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩13.77 Billion | 0.0% |
| Accounts Receivable | ₩8.61 Billion | 12.3% |
| Inventory | ₩7.59 Billion | 10.8% |
| Property, Plant & Equipment | ₩16.46 Billion | 23.4% |
| Intangible Assets | ₩142.46 Million | 0.2% |
| Goodwill | ₩2.53 Billion | 3.6% |
Asset Composition Trend (2015–2024)
This chart illustrates how Hana Must SPAC 2's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Hana Must SPAC 2 current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hana Must SPAC 2's current assets represent 62.6% of total assets in 2024, an increase from 46.1% in 2015.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 19.5% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 24.0% in 2015.
- Asset Diversification: The largest asset category is property, plant & equipment at 23.4% of total assets.
Hana Must SPAC 2 Competitors by Total Assets
Key competitors of Hana Must SPAC 2 based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
Hana Must SPAC 2 - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.12 | 7.28 | 1.40 |
| Quick Ratio | 5.42 | 5.77 | 1.11 |
| Cash Ratio | 0.00 | 1.98 | 0.00 |
| Working Capital | ₩36.54 Billion | ₩36.27 Billion | ₩6.15 Billion |
Hana Must SPAC 2 - Advanced Valuation Insights
This section examines the relationship between Hana Must SPAC 2's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.79 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 5.3% |
| Total Assets | ₩70.22 Billion |
| Market Capitalization | $36.86 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hana Must SPAC 2's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hana Must SPAC 2's assets grew by 5.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hana Must SPAC 2 (2015–2024)
The table below shows the annual total assets of Hana Must SPAC 2 from 2015 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩70.22 Billion ≈ $47.59 Million |
+5.31% |
| 2023-12-31 | ₩66.68 Billion ≈ $45.19 Million |
+47.83% |
| 2022-12-31 | ₩45.11 Billion ≈ $30.57 Million |
-7.91% |
| 2021-12-31 | ₩48.98 Billion ≈ $33.20 Million |
+8.52% |
| 2020-12-31 | ₩45.14 Billion ≈ $30.59 Million |
-4.18% |
| 2019-12-31 | ₩47.11 Billion ≈ $31.92 Million |
+14.17% |
| 2018-12-31 | ₩41.26 Billion ≈ $27.96 Million |
-24.57% |
| 2017-12-31 | ₩54.70 Billion ≈ $37.07 Million |
+20.26% |
| 2016-12-31 | ₩45.48 Billion ≈ $30.82 Million |
-3.75% |
| 2015-12-31 | ₩47.25 Billion ≈ $32.02 Million |
-- |
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more